Meeting
2020 ASCO Virtual Scientific Program
89Zr-durvalumab PD-L1 PET in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck.
Authors
Sarah Verhoeff
Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands
Sarah Verhoeff , Pim P van de Donk , Erik H.J.G. Aarntzen , Iris Harriëtte Cornelia Miedema , Sjoukje Oosting , Jens Voortman , Adrienne H. Brouwers , Marije Slingerland , Sandra Heskamp , Carla M.L.- Van Herpen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Clinical Trial Registration Number
NCT03829007
Citation
J Clin Oncol 38: 2020 (suppl; abstr 3573)
DOI
10.1200/JCO.2020.38.15_suppl.3573
Abstract #
3573
Poster Bd #
303
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Phase II study evaluating the efficacy of niraparib and dostarlimab (TSR-042) in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) patients.
First Author: Olga Zamulko
Poster
2021 Gastrointestinal Cancers Symposium
Phase II study of cabozantinib (cabo) combined with pembrolizumab (pembro) in metastatic or recurrent gastric and gastroesophageal adenocarcinoma (GEC) to overcome resistance to checkpoint inhibitors.
First Author: Farshid Dayyani
Poster
2017 ASCO Annual Meeting
A retrospective cohort study of PD-L1 expression in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SUPREME-HN).
First Author: Sara I. Pai
Poster
2015 ASCO Annual Meeting
KEYNOTE-055: A phase II trial of single agent pembrolizumab in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) who have failed platinum and cetuximab.
First Author: Steven Francis Powell